NHS should work with industry to assess new drugs

The NHS should work more closely with manufacturers on assessing the benefits of new medicines, rather than simply blocking access to them, the drug industry believes.

Speaking at a Westminster Health Forum event last week, Dr Richard Barker, director general of the Association of the British Pharmaceutical Industry, said that restricting access to drugs led to patients missing out on best care available.

This means patients cannot be included in many trials and creates a spiral in which care in the UK falls behind that in other countries, he said.

Dr Barker said NICE should recognise that there may be limited evidence when a drug is launched as to how well drugs worked in practice in different patient groups.

Rather than blocking access, the NHS should be allowed to use the drug and studies undertaken of how patients are benefitting, he said.

The NHS could then become a 'living laboratory for healthcare innovation', he said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Medico-legal: Intimate examinations and chaperones during COVID-19

Medico-legal: Intimate examinations and chaperones during COVID-19

Remote consultations are likely to be a key part of general practice for months to...

NHS England promises detail on additional flu funding ‘by end of August’

NHS England promises detail on additional flu funding ‘by end of August’

GPs may have to wait until the end of August to find out details of any additional...

Why 63% of GPs expect to do more home-working after COVID-19

Why 63% of GPs expect to do more home-working after COVID-19

Working from home was one of the key issues raised in GPonline's survey of more than...

Lack of support during the menopause leading female doctors to quit

Lack of support during the menopause leading female doctors to quit

A lack of support during the menopause has led some female doctors to consider reducing...

One in three single-handed GPs at high-risk from COVID-19

One in three single-handed GPs at high-risk from COVID-19

A third of single-handed GPs are at high-risk from COVID-19, which could potentially...

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Dr Mark Spencer explains how the COVID-19 pandemic helped his primary care network...